It is clearly shown in many studies that hyperphosphorylation and/or specific mutations can promote aggregation of the dissociated tau into PHF followed by NFT in many neurodegenerative diseases including AD (Fig. 2). This evidence concerns the gene MAPT and neurodegenerative disease.